PMI Impact Malaria (IM) is the flagship global service delivery project of the U.S. President's Malaria Initiative (PMI), providing global technical leadership to fight malaria and save lives. IM supports countries in their efforts to strengthen malaria diagnosis, treatment, and drug-based prevention in health facility and community settings through implementation and technical support, as well as operational research.
In the project’s third year, IM operated in 18 countries across Africa and Asia and supported USAID’s Bureaus for Latin America and the Caribbean (LAC) and Africa.
Using IM’s comprehensive and standardized quality assurance approach, called Outreach Training and Supportive Supervision Plus (OTSS+), IM made major strides in accelerating quality improvement of country-driven malaria services in health facilities. Through developing a digitized global package of OTSS+ checklists, IM enabled 10 countries to conduct facility-level supportive supervision of health worker competency in three main areas: 1) managing uncomplicated and severe malaria, 2) preventing and treating malaria in pregnancy (MIP), and 3) performing malaria rapid diagnostic tests and malaria microscopy.
The OTSS+ digital data entry platform allowed for real-time feedback and troubleshooting, along with prompt development of quality improvement action plans. Using these OTSS+ data, IM performed detailed cross-country analyses to gain a clearer picture of the gaps in health worker performance and health facility readiness for high-quality malaria service delivery. IM is working closely with all 10 countries to address the gaps identified.
In 2020, IM countries were successful in moving forward most planned activities despite the COVID-19 pandemic. This is a snapshot of country-driven achievements that IM supported during the past year:
IM’s COVID-19 Response
Under IM’s expanded mandate to include pandemic and epidemic response, IM developed and rolled out rapid COVID-19 guidance and training to health workers and laboratory technicians in Cameroon, DRC, and Ghana, which included providing essential hygiene supplies, generating critical data to inform response decisions, and training health workers on appropriate precautions for the pandemic context.
Altogether, the three countries trained 1,702 health workers. IM also modified current OTSS+ checklists to strengthen assessment of competencies in infection prevention and control and clinical and laboratory diagnosis of COVID-19. Lastly, IM developed six e-learning modules for health workers, in both English and French, that will enable countries to further expand training in COVID-19 infection prevention and control, and biosafety.
Read IM's latest blog posts to learn more about the human impact of IM’s country-driven work.
Header Photo Caption: Community health worker Jean Ngouoli explains antimalarial medication doses to Boussota, mother of two-year-old Sidonie, in Mouda, Cameroon during the fourth cycle of Cameroon's 2020 seasonal malaria chemoprevention (SMC) campaign. Credit: PMI Impact Malaria.
PMI Impact Malaria is led by Population Services International (PSI) in partnership with Jhpiego, Medical Care Development International (MCDI), and the Malaria Elimination Initiative (MEI) at UC San Francisco.
The information provided on this website is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.